Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical products

5 Mar 2024

Abstract excerpt

BACKGROUND AIMS: Few human induced pluripotent stem cell (hiPSC) lines are Good Manufacturing Practice (GMP)-compliant, limiting the clinical use of hiPSC-derived products. Here, we addressed this by establishing and validating an in-house platform to produce GMP-compliant hiPSCs that would be appropriate for producing both allogeneic and autologous hiPSC-derived products. METHODS: Our standard research protocol...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Pancreatic function and diabetes
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38483359
DOI: 10.1016/j.jcyt.2024.02.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical productsPMID 38483359Read ↗

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ LayersSemantic proximity Read ↗

GMP-compatible manufacturing of three iPS cell lines from human peripheral bloodSemantic proximity Read ↗

Validation of a library of cGMP-compliant human pluripotent stem cell lines for use in liver therapySemantic proximity Read ↗

Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives.Semantic proximity Read ↗

Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

From Skin Biopsy to Neurons Through a Pluripotent Intermediate Under Good Manufacturing Practice ProtocolsSemantic proximity Read ↗

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical ApplicationsSemantic proximity Read ↗

Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell LinesSemantic proximity Read ↗

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cellsSemantic proximity Read ↗

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatmentSemantic proximity Read ↗

Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditionsSemantic proximity Read ↗

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.